Literature DB >> 1553354

Colonic drug delivery: enhanced release of indomethacin from cross-linked chondroitin matrix in rat cecal content.

A Rubinstein1, D Nakar, A Sintov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1553354     DOI： 10.1023/a:1018910128452

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  7 in total

Review 1.  ["Targeted delivery" in the gastrointestinal tract].

Authors:  C S Leopold
Journal:  Med Klin (Munich)       Date:  1999-02-15

2.  The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery.

Authors:  D A Adkin; C J Kenyon; E I Lerner; I Landau; E Strauss; D Caron; A Penhasi; A Rubinstein; I R Wilding
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

3.  Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

Authors:  Rajkumar Malayandi; Phani Krishna Kondamudi; P K Ruby; Deepika Aggarwal
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

4.  In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier.

Authors:  A Rubinstein; R Radai; M Ezra; S Pathak; J S Rokem
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

5.  Nanometer- and submicrometer-sized hollow spheres of chondroitin sulfate as a potential formulation strategy for anti-inflammatory encapsulation.

Authors:  Adriano V Reis; Marcos R Guilherme; Luiz H C Mattoso; Adley F Rubira; Elias B Tambourgi; Edvani C Muniz
Journal:  Pharm Res       Date:  2008-11-13       Impact factor: 4.200

6.  Polymers for colon targeted drug delivery.

Authors:  H Rajpurohit; P Sharma; S Sharma; A Bhandari
Journal:  Indian J Pharm Sci       Date:  2010-11       Impact factor: 0.975

7.  Formulation and evaluation of chondroitin sulphate tablets of aceclofenac for colon targeted drug delivery.

Authors:  Thiruganesh Ramasamy; Umadevi Subbaih Khandasamy; Suresh Shanmugam; Himabindhu Ruttala
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.